Huang James 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-10-29 4:05 pm Purchase |
2024-09-30 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,435,000 9.200% |
305,000 (+26.99%) |
Filing |
| 2024-06-11 4:10 pm Sale |
2024-06-10 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,130,000 8.400% |
-1,565,000 (-58.07%) |
Filing |
| 2024-01-26 08:31 am Purchase |
2024-01-25 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 2,695,000 19.990% |
268,000 (+11.04%) |
Filing |
| 2023-11-09 4:13 pm Purchase |
2023-11-09 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 2,427,000 18.000% |
677,000 (+38.69%) |
Filing |
| 2023-06-22 9:15 pm Purchase |
2023-06-16 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,750,000 13.000% |
520,000 (+42.28%) |
Filing |
| 2023-04-10 11:22 am Purchase |
2023-03-29 | 13G | CASI Pharmaceuticals, Inc. CASI |
Huang James | 1,230,000 9.200% |
1,230,000 (New Position) |
Filing |